Barclays Maintains Overweight on Universal Health Servs, Raises Price Target to $271

Benzinga · 10/25 18:06
Barclays analyst Andrew Mok maintains Universal Health Servs (NYSE:UHS) with a Overweight and raises the price target from $256 to $271.